Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SNX-111 study in head trauma resumed

Sep. 30, 1997

No Comments

Seroquel cleared for marketing in U.S.

Sep. 30, 1997

No Comments

Rhone-Poulenc Rorer discloses new AMPA/NMDA receptor antagonists

Sep. 30, 1997

No Comments

Symphony discloses AMPA antagonists

Sep. 30, 1997

No Comments

Clinical pharmacokinetics and safety reported for Sankyo's MAO-A inhibitor

Sep. 30, 1997

No Comments

Oral and nasal sumatriptan studied for migraine

Sep. 30, 1997

No Comments

Phase II trial begins for Neurobiological Technologies' antiedema agent

Sep. 29, 1997

No Comments

ICOS commences phase II trial for ischemic stroke; analyzes data for other indications

Sep. 29, 1997

No Comments

Rhone-Poulenc Rorer discloses excitatory amino acid antagonists

Sep. 29, 1997

No Comments

New morphinoid delta-opioid ligands from SmithKline Beecham

Sep. 29, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

SNX-111 study in head trauma resumed

Seroquel cleared for marketing in U.S.

Rhone-Poulenc Rorer discloses new AMPA/NMDA receptor antagonists

Symphony discloses AMPA antagonists

Clinical pharmacokinetics and safety reported for Sankyo's MAO-A inhibitor

Oral and nasal sumatriptan studied for migraine

Phase II trial begins for Neurobiological Technologies' antiedema agent

ICOS commences phase II trial for ischemic stroke; analyzes data for other indications

Rhone-Poulenc Rorer discloses excitatory amino acid antagonists

New morphinoid delta-opioid ligands from SmithKline Beecham

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Neurology/psychiatric RSS

Neurology/psychiatric
RSS